Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

2.0K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.0K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

347
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
347
Cancer Vaccines01:30

Cancer Vaccines

1.1K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.1K
Cancer Therapies02:49

Cancer Therapies

10.2K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

561
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
561

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-world prognostic assessment of the HERO score in metastatic urothelial carcinoma treated with enfortumab vedotin (ARON-2EV study).

ESMO open·2026
Same author

A rare case of angiosarcoma of the ureter.

Discover oncology·2026
Same author

Carcinoid syndrome with right-sided valve involvement - a case report and review of the literature.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2024
Same author

Appendiceal tumors and pseudomyxoma peritonei: current recommendations for clinical practice.

Rozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti·2023
Same author

Isatuximab plus atezolizumab in patients with advanced solid tumors: results from a phase I/II, open-label, multicenter study.

ESMO open·2022
Same author

Cabozantinib in the treatment of metastatic renal cell carcinoma - final data analysis from four oncology centers in the Czech Republic.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2021

Related Experiment Video

Updated: Feb 17, 2026

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors
15:24

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Published on: December 16, 2022

4.0K

[Combined Regimens in Immunotherapy].

B Melichar, M Spisarová

    Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti
    |December 15, 2017
    PubMed
    Summary

    Combination immunotherapy, including ipilimumab and nivolumab, shows promise for metastatic cancers like melanoma and renal cell carcinoma. Further trials will determine the full potential of these novel treatment strategies.

    Area of Science:

    • Oncology
    • Immunology

    Background:

    • Immunotherapy has transformed metastatic cancer management, offering durable responses and better tolerance compared to traditional therapies.
    • While often palliative, metastatic cancer treatment is evolving with immunotherapy's broad applicability across tumor types.

    Purpose of the Study:

    • To review the current landscape and future potential of combination immunotherapy regimens in treating metastatic cancers.
    • To highlight the efficacy and safety of combining ipilimumab and nivolumab in specific metastatic conditions.

    Main Methods:

    • Review of current clinical data and ongoing trials involving combination immunotherapy.
    • Focus on ipilimumab and nivolumab combinations for metastatic malignant melanoma and renal cell carcinoma.
    • Exploration of other combination strategies, including with chemotherapy, radiotherapy, and surgery.

    More Related Videos

    Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
    15:04

    Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

    Published on: January 19, 2019

    12.8K
    Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
    09:15

    Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

    Published on: February 24, 2023

    4.1K

    Related Experiment Videos

    Last Updated: Feb 17, 2026

    Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors
    15:24

    Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

    Published on: December 16, 2022

    4.0K
    Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
    15:04

    Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

    Published on: January 19, 2019

    12.8K
    Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
    09:15

    Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

    Published on: February 24, 2023

    4.1K

    Main Results:

    • Combination immunotherapy, particularly ipilimumab with nivolumab, demonstrates significant promise in metastatic melanoma and renal cell carcinoma.
    • Supportive care effectively manages treatment-related toxicities, enabling combination immunotherapy to become a standard option.
    • Ongoing trials are investigating ipilimumab and nivolumab for other cancers and exploring novel combinations.

    Conclusions:

    • Combination immunotherapy represents a promising, albeit nascent, strategy in oncology.
    • Further clinical trials are essential to fully realize the potential of combination immunotherapy regimens in meeting clinical expectations.